Sanket Rathod

Sanket Rathod

Auto-generated profile, based on publicly available information

Sanket Rathod

Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur 416013, Maharashtra, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in ACS Omega
Verified
Journal Article
Open access
SRSanket Rathod
Sanket Rathod
KSKetaki Shinde
Ketaki Shinde
JPJaykedar Porlekar
Jaykedar Porlekar
PCPrafulla Choudhari
Prafulla Choudhari
RDRakesh Dhavale
Rakesh Dhavale
MPMehboobali Pannipara
Mehboobali Pannipara
Over the centuries, cancer has been considered one of the significant health threats. It holds the position in the list of deadliest diseases over the globe. In women, breast cancer is the most common among many cancers and is the second most common cancer all over the world, while lung cancer is the first. Cyclin-dependent kinase 8 (CDK8) has been identified as a critical oncogenic driver that is found in breast cancer and associated with tumor progression. Flavonoids were virtually screened against CDK8 using molecular docking, drug-likeness, ADMET prediction, and a molecular dynamics (MD) simulation approach to determine the potential flavonoid structure against CDK8. The results indicated that ZINC000005854718 showed the highest negative binding affinity of -10.7 kcal/mol with the targeted protein and passed all the drug-likeness parameters. Performed molecular dynamics simulation showed that docked complex systems have good conformational stability over 100 ns in different temperatures (298, 300, 305, 310, and 320 K). The comparison between calculated binding free energy via MM/PB(GB)SA methods and binding affinity calculated via molecular docking suggested tight binding of ZINC000005854718 with targeted protein. The results concluded that ZINC000005854718 has drug-like properties with tight and stable binding with the targeted protein.

17 May 2024 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
UMUdhav V. Mhetre
Udhav V. Mhetre
NHNitin B. Haval
Nitin B. Haval
GBGiribala M. Bondle
Giribala M. Bondle
SRSanket S. Rathod
Sanket S. Rathod
PCPrafulla B. Choudhari
Prafulla B. Choudhari
KHKishan P. Haval
Kishan P. Haval

15 September 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
RBRajubai D. Bakale
Rajubai D. Bakale
ABAmruta N. Bhagat
Amruta N. Bhagat
UMUdhav V. Mhetre
Udhav V. Mhetre
SLShyam V. Londhe
Shyam V. Londhe
SRSanket S. Rathod
Sanket S. Rathod
KHKishan P. Haval
Kishan P. Haval

19 April 2023 in Natural Product Research
Verified
Journal Article
Closed access
SRSneha Rochlani
Sneha Rochlani
MBManish Bhatia
Manish Bhatia
SRSanket Rathod
Sanket Rathod
PCPrafulla Choudhari
Prafulla Choudhari
RDRakesh Dhavale
Rakesh Dhavale
Limonoids serve as vital secondary metabolites. Citrus limonoids show a wide range of pharmacological potential. As a result of which limonoids from citrus are of considerable research interest. Identification of new therapeutic molecules from natural origins has been widely adopted as a successful strategy in drug discovery. This work mainly focused on the high-throughput computational exploration of the antiviral potential of three vital limonoids, i.e. Obacunone, Limonin and Nomilin against spike proteins of SARS CoV-2 (PDB:6LZG), Zika virus NS3 helicase (PDB:5JMT), Serotype 2 RNA dependent RNA polymerase of dengue virus (PDB:5K5M). Herein we report the molecular docking, MD simulation studies of nine docked complexes, and density functional theory (DFT) of selected limonoids. The results of this study indicated that all three limonoids have good molecular features but out of these three obacunone exerted satisfactory results for DFT, docking and MD simulation study. Graphical Abstract

28 March 2024 in ACS Omega
Verified
Journal Article
Open access
NLNarayanaswamy Lohitha
Narayanaswamy Lohitha
PKPeruru Hemanth Kumar
Peruru Hemanth Kumar
SSSarveswari Sundaramoorthy
Sarveswari Sundaramoorthy
SRSanket Rathod
Sanket Rathod
SCSomdatta Chaudhari
Somdatta Chaudhari
Vijayakumar VijayaparthasarathiVijayakumar Vijayaparthasarathi
Vijayakumar Vijayaparthasarathi
A series of novel 24 phenylhydrazono phenoxyquinoline derivatives were synthesized with moderate to excellent yield and screened for their efficacy against the α-amylase enzyme through in silico studies. The structures were characterized using spectroscopic techniques such as 1HNMR, 13CNMR, and HREI-MS. Comprehensive computational studies including, drug-likeness and ADMET profiling, quantum chemical calculations, molecular docking, and molecular dynamics (MD) simulation studies, were performed. A density functional theory study of the synthesized compounds indicated a favorable reactivity profile. The synthesized novel analogues were docked against α-amylase (PDB 6OCN) enzymes to investigate the binding interactions. Based on the docking studies, one of the compounds was found to be the hit with the highest negative binding affinity for α-amylase. A MD simulation study indicated stable binding throughout the simulation.

9 January 2023 in Natural Product Research
Verified
Journal Article
Closed access
VBVarun Kishor Bagal
Varun Kishor Bagal
SRSanket Somnath Rathod
Sanket Somnath Rathod
MMMuskan Musa Mulla
Muskan Musa Mulla
SPSwaranjali Chandrakant Pawar
Swaranjali Chandrakant Pawar
PCPrafulla Balkrishna Choudhari
Prafulla Balkrishna Choudhari
DMDeepak Vamanrao Mahuli
Deepak Vamanrao Mahuli
Tinospora cordifolia and Actinidia deliciosa are the widely used plant in Ayurvedic systems of medicine. Both plants are well known for their immunomodulatory activity. In the current study, in silico exploration was performed using advanced computational techniques such as molecular docking and molecular dynamics simulation approach. Bioactive molecules from the Tinospora cordifolia and Actinidia deliciosa were docked against the Human IL-2. Out of all the docked bioactive molecules, Pygenic acid-B (PubChem CID:146157192) showed the highest negative binding affinity. Graphical Abstract